123 related articles for article (PubMed ID: 23363926)
1. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Charcot-Marie-Tooth disease in the population of Belgrade, Serbia.
Mladenovic J; Milic Rasic V; Keckarevic Markovic M; Romac S; Todorovic S; Rakocevic Stojanovic V; Kisic Tepavcevic D; Hofman A; Pekmezovic T
Neuroepidemiology; 2011; 36(3):177-82. PubMed ID: 21546779
[TBL] [Abstract][Full Text] [Related]
3. Survival and mortality of adult-onset myasthenia gravis in the population of Belgrade, Serbia.
Basta I; PekmezoviĆ T; Peric S; NikoliĆ A; RakoČeviĆ-StojanoviĆ V; SteviĆ Z; LavrniĆ D
Muscle Nerve; 2018 Nov; 58(5):708-712. PubMed ID: 29572981
[TBL] [Abstract][Full Text] [Related]
4. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
5. Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.
Foldvari A; Kovacs N; Sipos V; Merth G; Vincze F; Szucs M; Sandor J
Wien Klin Wochenschr; 2015 Jun; 127(11-12):459-64. PubMed ID: 25990531
[TBL] [Abstract][Full Text] [Related]
6. Incidence of myasthenia gravis in the province of Ferrara: a community-based study.
Casetta I; Fallica E; Govoni V; Azzini C; Tola M; Granieri E
Neuroepidemiology; 2004; 23(6):281-4. PubMed ID: 15297794
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992).
Lavrnić D; Jarebinski M; Rakocević-Stojanović V; Stević Z; Lavrnić S; Pavlović S; Trikić R; Tripković I; Nesković V; Apostolski S
Acta Neurol Scand; 1999 Sep; 100(3):168-74. PubMed ID: 10478580
[TBL] [Abstract][Full Text] [Related]
8. Geographical distribution of a seropositive myasthenia gravis population.
Heldal AT; Eide GE; Gilhus NE; Romi F
Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of myasthenia gravis].
Pekmezović T; Lavrnić D; Jarebinski M; Apostolski S
Srp Arh Celok Lek; 2006; 134(9-10):453-6. PubMed ID: 17252917
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of seropositive myasthenia gravis in Greece.
Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
[TBL] [Abstract][Full Text] [Related]
11. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
[TBL] [Abstract][Full Text] [Related]
12. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.
Pedersen EG; Hallas J; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2013 Feb; 20(2):309-14. PubMed ID: 22882327
[TBL] [Abstract][Full Text] [Related]
13. The rising incidence and mortality of prostate cancer in Belgrade population.
Janković J; Sipetić S
Coll Antropol; 2011 Jun; 35(2):499-503. PubMed ID: 21755724
[TBL] [Abstract][Full Text] [Related]
14. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
Alshekhlee A; Miles JD; Katirji B; Preston DC; Kaminski HJ
Neurology; 2009 May; 72(18):1548-54. PubMed ID: 19414721
[TBL] [Abstract][Full Text] [Related]
15. [Trends in mortality in Serbia, excluding the provinces, 1973-1994].
Vlajinac H; Marinković J; Kocev N; Adanja B; Sipetić S; Pekmezović T; Zivaljević V
Srp Arh Celok Lek; 2000; 128(9-10):309-15. PubMed ID: 11255684
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence and prevalence of Balkan endemic nephropathy in the three most affected villages in Serbia over a 36-year period.
Janković S; Bukvić D; Marinković J; Janković J; Marić I; Djukanović L
Ren Fail; 2013; 35(4):509-13. PubMed ID: 23485103
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of myasthenia gravis in Ontario, Canada.
Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of myotonic dystrophy type 1 (Steinert disease) in Belgrade (Serbia).
Mladenovic J; Pekmezovic T; Todorovic S; Rakocevic-Stojanovic V; Savic D; Romac S; Apostolski S
Clin Neurol Neurosurg; 2006 Dec; 108(8):757-60. PubMed ID: 16713671
[TBL] [Abstract][Full Text] [Related]
20. Time trends in Balkan endemic nephropathy incidence in the most affected region in Serbia, 1977-2009: the disease has not yet disappeared.
Janković S; Bukvić D; Marinković J; Janković J; Marić I; Djukanović L
Nephrol Dial Transplant; 2011 Oct; 26(10):3171-6. PubMed ID: 21355065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
